REG - Surgical Innovations - Directorate Change

Surgical InnovationsAnnouncement

19/12/2023 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20231219:nRSS2188Xa&default-theme=true

RNS Number : 2188X  Surgical Innovations Group PLC  19 December 2023

Surgical Innovations Group Plc

 ("Surgical Innovations", the "Company" or the "Group")

 

Directorate Change

 

Surgical Innovations Group Plc (AIM: SUN), the designer, manufacturer and
distributor of innovative technology for minimally invasive surgery, announces
that Charmaine Day has notified the Board of her intention to step down from
her role as Chief Financial Officer ('CFO') and Company Secretary in order to
pursue other opportunities.

 

The Company will begin an extensive search to find the correct candidate for
the CFO position and an orderly transition process will take place, aided by
Charmaine, ahead of her departure from Surgical Innovations. Charmaine has
committed to stay until the transition to her successor is complete.

 

CEO, David Marsh, commented: "It has been a pleasure to work with Charmaine
since she joined Surgical Innovations in 2012, and especially in the role of
CFO since 2021, and I would like to thank her for the excellent and continued
contribution that she brings to the business.

 

"We will begin the search imminently to find a new CFO and will effect an
orderly handover once the right candidate has been selected, with both aspects
of the transition supported by Charmaine. We look forward to providing an
update in due course."

 

The Company's next scheduled trading update will be late January 2024

 

For further information please contact:

 

 Surgical Innovations Group plc                                                 www sigroupplc com (http://www.sigroupplc.com/)
 David Marsh, CEO                                                               Tel: 0113 230 7597

 Charmaine Day, CFO

 Singer Capital Markets (Nominated Adviser & Broker)                                                        Tel: 020 7496 3000
 Aubrey Powell / Oliver Platts

 Walbrook PR (Financial PR & Investor Relations)      Tel: 020 7933 8780 or si@walbrookpr.com (mailto:si@walbrookpr.com)
 Paul McManus / Charlotte Edgar / Alice Woodings                                Mob: 07980 541 893 / 07584 391 303 / 07407 804 654

 

 

About Surgical Innovations Group plc

The Group specialises in the design, manufacture, sale and distribution of
innovative, high quality medical products, primarily for use in minimally
invasive surgery. Our product and business development is guided and supported
by a key group of nationally and internationally renowned surgeons across the
spectrum of minimally invasive surgical activity.

 

We design and manufacture and source our branded port access systems, surgical
instruments and retraction devices which are sold directly in the UK home
market through our subsidiary, Elemental Healthcare, and exported widely
through a global network of trusted distribution partners. Many of our
products in this field are based on a "resposable" concept, in which the
products are part reusable, part disposable, offering a high quality and
environmentally responsible solution at a cost that is competitive against
fully disposable alternatives.

 

Elemental also has exclusive UK distribution for a select group of specialist
products employed in laparoscopy, bariatric and metabolic surgery, hernia
repair and breast reconstruction.

 

In addition, we design and develop medical devices for carefully selected OEM
partners and have also collaborated with a major UK industrial partner to
provide precision engineering solutions to complex problems outside the
medical arena.

 

We aim for our brands to be recognised and respected by healthcare
professionals in all major geographical markets in which we operate and
provide by development, partnership or acquisition a broad portfolio of cost
effective, procedure specific surgical instruments and implantable devices
that offer reliable solutions to genuine clinical needs in the operating
theatre environment.

 

Further information

Further details of the Group's businesses and products are available on the
following websites:

www.sigroupplc.com (http://www.sigroupplc.com)

www.surginno.com (http://www.surginno.com)

www.elementalhealthcare.co.uk (http://www.elementalhealthcare.co.uk)

 

To receive regular updates by email, please contact si@walbrookpr.com
(mailto:si@walbrookpr.com)

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  BOAGPGMGPUPWPGR